Schizophrenia Research Forum - A Catalyst for Creative Thinking


Buckley PF, Miller DD, Singer B, Arena J, Stirewalt EM. Clinicians' recognition of the metabolic adverse effects of antipsychotic medications. Schizophr Res. 2005 Jun 17 ; Pubmed Abstract

Comments on Related News


Related News: Looking for Silver Linings in Clozapine’s Side Effects

Comment by:  Steven Erickson
Submitted 19 July 2006
Posted 19 July 2006
  I recommend the Primary Papers

These are solid studies. I wonder, though, how many of these patients are on statins to prevent atherosclerosis? Is there evidence that people with schizophrenia at risk of atherosclerosis (perhaps most of them?) are routinely given proper cardiovascular medicine?

View all comments by Steven Erickson